Abstract: Stable tethering of bioactive peptides like RGD to surfaces can be achieved via chemical bonding, biotin streptavidin interaction, or photocross-linking. More challenging is the immobilization of proteins, since methods applied to immobilize peptides are either not specific or versatile enough or might even compromise the protein's bioactivity. To overcome this limitation, we have employed a scheme that by enzymatic (transglutaminase) reaction allows the site-directed and site-specific coupling of growth factors and other molecules to nonfouling poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) coated surfaces under physiological conditions. By our modular and flexible design principle, we are able to functionalize these surfaces directly with peptides and growth factors or precisely position poly(ethylene glycol) (PEG)-like hydrogels for the presentation of growth factors as exemplified with vascular endothelial growth factor (VEGF). 2
Introduction
Cells under physiological conditions are embedded within the extracellular matrix (ECM), a viscoelastic highly hydrated network that is mainly composed of glycosaminoglycans and fibrillar proteins. This ECM is not only responsible for structural integrity of tissues but also stores and presents complex spatiotemporal arrays of biochemical and biophysical signals [1] [2] [3] [4] that regulate the dynamic behavior of cells or even whole tissues. Many growth factors are matrix bound and thus, only limited available to cells in quiescent tissues. Furthermore, matrix binding might restrict the diffusion of growth factors from the site of production, protect them from proteolytic degradation, and modulate their activity by coordination of integrin and tyrosine kinase receptor signaling. At this stage we are far from understanding the complex cell-matrix and cell-cell interactions involved in tissue formation, homeostasis, healing, and pathology. In order to study such events and to manipulate cellular behavior, test systems that in a predictable and biologically relevant manner present bioactive entities such as growth factors and cytokines are necessary.
To mimic such complex in vivo environments, recent strategies take advantage of the virtual deconstruction of the ECM components into functional subunits, such as cell adhesion ligands, substrates for proteolytic enzymes, and immobilization of regulatory proteins 2, [5] [6] .
Protein and peptide components are synthesized by either chemical or by recombinant technologies, and incorporated by chemical, physical or biological means in a well-defined fashion either on surfaces [7] [8] [9] [10] or in three-dimensional (3D) matrices 2, 5, [11] [12] . Since in the naturally occurring situation multiple bioactive signals are presented in a tightly controlled tempero-spatial manner and in variable concentrations, such models should ideally be flexible and versatile enough to specifically, precisely and locally incorporate complex combinations and arrangements of motifs upon a passive background. Most important, mainly regarding incorporation of full proteins, the strategy used to stably immobilize bioligands should be mild enough to not compromise the protein's bioactivity.
While strategies to spatially arrange bioligands in 3D are only beginning to be explored, modification and patterning strategies on surfaces are much further advanced and have been used to study cell-matrix interactions and to develop biomedical implants with improved healing and performance 13 . For example, surfaces modified with the well-known integrin peptide ligand RGD provided insight into substrate requirements for cell adhesion [14] [15] [16] [17] or cell migration 18 ; into nanoscale spatial organization 15, [19] [20] and clustering of integrin receptors [21] [22] [23] [24] [25] [26] . These studies have become possible due to the advances in micro-and nano-fabrication technologies 8, 10, 24 that have allowed for the production of density-and space-controlled immobilization of RGD binding peptides on non-fouling substrates like agarose, pluronics, and poly(ethylene glycol) (PEG), to prevent non-specific protein and cell adhesion. The arrangement of RGD peptides has for example been achieved by positioning of gold nanoparticles with immobilized cyclic RGD peptides on a bioinert PEG background. In an elegant system named molecular assembly patterning by lift off (MAPL) 27 , conventional photolithography is employed to create defined nano-and micropatterns of functionalized poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) macromers on a non-fouling background. PLL-g-PEG-based copolymers were directly conjugated with cell adhesion ligands, such as RGD [27] [28] [29] , or with biotin which gives the possibility to immobilize different avidin-containing ligands at once 30 .
In contrast to the relatively easy procedures to functionalize passive backgrounds with RGD peptides, the development of platforms that allow for the immobilization and arrangement of proteins, has been hindered by the many obstacles related to protein's specific features. In order to not compromise the stability and activity of the proteins, sufficiently mild strategies that allow for site-specific and stable tethering of ligands which are compatible with the above mention technologies are needed. In recent years, some reports on successful immobilization of growth factors to surfaces by the use of different chemical, physical and biological means have been reported. Ichiose et al. described a direct chemical coupling of epithelial growth factor (EGF) to thiol modified glass-substrates using maleimide reactive groups previously conjugated to primary amine groups of the protein 31 . In another approach EGF was covalently immobilized to the hydroxyl-activated chains of coated poly(methyl methacrylate)-graftpoly(ethylene oxide) (PMMA-g-PEO) on glass slides 32 . Soluble acryol-PEG-transforming growth factor-β1 (acryol-PEG-TGF-β1) has been proven to retain part of its bioactivity when added on glass slides modified with acryolyl-PEG-adhesive peptides 33 . Photo-immobilization strategies have been used to conjugate gradients of EGF and IGF-1 (insulin-like growth factor) modified to contain photoreactive groups onto polystyrene 34 . In an elegant strategy the group of Segura has taken advantage of the heparin-binding activity of vascular endothelial growth factor (VEGF) to "dock" and correctly orient the growth factor on heparin substrates.
In a second step they use a photoreactive group to covalently "lock" the growth factor onto the surface 35 . Although chemical reactions have proven to be suitable for the tethering of growth factors to surfaces, the existing immobilization regimen lack versatility and general applicability since they are not compatible with a broad range of growth factors, and often might not result in a site-specific and properly oriented tethering of active proteins. Moreover, it is desirable to integrate such strategies in a micro-patterning context.
4
Enzymatic tethering of growth factors to substrates has been reported to be highly specific and due to mild reaction conditions are compatible with protein's functionality 36 . For example transglutaminases, enzymes that rely on Ca 2+ and introduce covalent cross-links between glutamine residues (glutamine donor) and lysine residues (glutamine acceptor), have been used to immobilize engineered enzymes or single-chain antibody fragments on amineterminated sepharose or on surfaces previously modified to contain casein in an active state [37] [38] . In previous work we have shown that factor XIIIa (FXIIIa), a transglutaminase isoenzyme, can be employed to cross-link star-shaped poly(ethylene glycol) (PEG) polymers that are functionalized with either a glutamine acceptor (Ac-FKGG) 39 or a glutamine donor (H-NQEQVSPL) 40 , here named; Lys substrate or TG substrates respectively, to form synthetic hydrogels [41] [42] . The fidelity and specificity of the enzymatic reaction [43] [44] [45] , which takes place under physiological conditions is compatible with the protein functionality and could be applied simultaneously to tether growth factors and other ligands to the forming matrix [41] [42] .
In this study we describe a scheme that relies on the FXIIIa-enzymatic immobilization of biologically active ligands, including peptides and proteins on PLL-g-PEG coated surfaces.
We show the specificity of the surface modification by Optical Waveguide Light Model Spectroscopy (OWLS) on PLL-g-PEG-based non-fouling surfaces. We demonstrate that this scheme is compatible with the well-established MAPL technology by creation of defined patterns of RGD and VEGF upon a passive PLL-g-PEG background. Initial results also indicate that based on consecutive enzymatic reactions, oriented build-up of surfaceimmobilized hydrogel-like structures could be achieved in well-defined positions, giving the possibility to site-specifically deposit relatively large quantities of biologically active substances on a surface.
Materials and Methods
All experiments (unless indicated) were performed in HEPES buffer, consisting of 10 mM 4-(2-hydroxyethyl)-piperazine-1-ethane-sulfonic acid and 150 mM NaCl (Sigma Aldrich, Buchs, CH). The pH of the solution was adjusted to pH 7.4 using 6 M NaOH (Fluka, Buchs, CH). All aqueous solutions were prepared using ultrapure water filtered through MilliQ gradient A 10 filters (Millipore AG, CH).
Poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) polymers
Commercially available PLL 20 50 µl of β-mercaptoethanol (Fluka, Buchs, CH) was used for quenching and prior to freezedrying, the mixture was dialyzed against deionized water for 48 hours. Synthesized PLL-g-PEG-TG resulted in a white powder and was kept frozen at -20°C before use.
Grafting ratio g and fraction of peptide-functionalized PEG-chains were determined by Nuclear Magnetic Resonance Spectroscopy ( Figure S2 ). The grafting ratio and the 6 adsorbed polymer mass allowed us to determine the surface densities of the immobilized peptide moieties 29, 48 .
PEG and peptides
Star-shaped 8-arm PEG, mol wt 40,000 g/mol, was purchased from Nektar (Huntsville, AL). PEG vinylsulfone (PEG-VS) was produced and characterized as described elsewhere 49 . In a second step, PEG-VS were functionalized with Lys and TG substrates via Michel-type addition to give TG-PEG and Lys-PEG precursors. Functionalization and characterization of these precursors was performed as described elsewhere 42 . In brief, peptides were added to PEG-VS in a 1.2 fold molar excess over VS groups in 0.3 M triethanolamine (pH 8.0) at 37 °C for 2 h, followed by dialysis (Snake Skin, MWCO 10k, PIERCE, Rockford, IL, USA) against ultrapure water for 4 days at 4 °C.
Activation of FXIII by thrombin
100 µl of FXIII (200 U/ml, Fibrogammin P1250 CSL Behring) was activated in presence of 2.5 mM CaCl 2 with 10 µl of thrombin (20 U/ml, Sigma-Aldrich, CH) for 30 min at 37 °C.
Small aliquots (200 U/ml) of activated factor XIIIa were stored at -80 °C for further use [41] [42] .
Cell culture

MC3T3-E1 mouse preosteoblastic cells from American Type Culture Collection (ATCC,
Manassas, VA, USA) were grown in alpha-minimal essential medium (Gibco, Invitrogen, CH) supplemented with 10% (v/v) FBS at 37 °C and 5% CO 2 . Cells were trypsinized and passaged every 2 to 3 days. Cultures were never allowed to become confluent.
Optical Waveguide Light Model Spectroscopy (OWLS)
OWLS is an optical technique that allows for determining the adsorbed mass on a surface based on changes in the refractive index on the vicinity of the surface upon adsorption of molecules from solution. More details about this technique can be found elsewhere 50 . The instrument (OWLS 120) and the waveguides were obtained from MicroVacuum Ltd.
(Budapest, H). Waveguides were sputter-coated with 6 nm TiO 2 at PSI (Villigen, CH).
Shortly prior to use, waveguides were cleaned by ultrasonication for 10 min in 2-propanol and for 10 min in ultra-pure water, subsequently blown dried with filtered nitrogen and oxygen and plasma cleaned for 2 min (PDC-32 G. Harrick Plasma).
For each experiment, the waveguide was mounted into a flow-through cell (15 µl volume) and HEPES was introduced. After stabilization of the buffer baseline, PLL-g-PEG-TG was injected and allowed to adsorb for at least 15 min before rinsing with HEPES. The protein resistance of the polymer was tested by injection of 3% bovine serum albumin (BSA) in HEPES. Subsequently, the surface was then exposed for 5 min to 25 mM CaCl 2 in HEPES, rinsed with HEPES and the resistance of the polymer layer tested again with 3% BSA. 
Molecular Assembly Patterning by Lift off (MAPL)
MAPL is a technique that allows for the production of micropatterns on a non-fouling surface via combination of conventional photolithography and assembly of functional PEG-graft polycationic copolymers on a negatively charged oxide-coated wafer. More details about this technique can be obtained elsewhere 27 . In brief, a photoresist layer was patterned (squares of 60 x 60 µm) on a Nb 2 O 5 -coated MAPL wafer (ca. 10cm) by spin coating the surface with a photoresist, UV illumination through a mask and finally development. Afterwards, wafers were diced in 1 x 1 cm chips. Shortly before use, chips were cleaned by ultrasonication for 10 min in ultra-pure water, dried with filtered nitrogen and oxygen plasma cleaned for 2 seconds.
Subsequently either PLL-g-PEG-TG (0.5 mg/ml) or PLL-g-PEG-FITC (0.5 mg/ml) were immobilized on the unprotected areas of the substrate by spontaneous assembly from aqueous solution, followed by lift off of the photoresist in 1-methyl-2-pyrrollidone (NMP). In order to render the surface resistant to non-specific protein adsorption, bare metal oxide areas were backfilled with PLL-g-PEG.
PLL-g-PEG, PLL-g-PEG-FITC and PLL-g-PEG-TG stocks (lyophilized white powder, kept frozen at -20 °C) were equilibrated at room temperature for 5 min prior to use and dissolved in HEPES 2 buffer to reach a final concentration of 0.5 mg/ml. Solutions were stored at -20 °C and warmed up to room temperature before use. 
Results and Discussion
FXIIIa, involved in the fibrin clot formation, is an activated transglutaminase that catalyzes an acyl-transfer reaction between the R-carboxamide group of protein-bound glutaminyl (Gln, or Q in the single letter nomenclature) residues and the ε-amino group of lysyl (Lys, or K) residues, resulting in the formation of ε-(α-glutamyl) lysine isopeptide side-chain bridges [44] [45] .
In the initial step, FXIIIa interacts in a specific manner with the glutamine substrate which results in the formation of a thioester bond between the enzyme and the substrate and the release of ammonia. Afterwards, this enzyme-glutamine complex binds to the primary amine of the lysine containing substrate leading to an isopeptide bridge between the glutamine and the lysine, with the subsequent release of the enzyme [43] [44] . In previous work we have shown that FXIIIa can be employed to crosslink star-shaped PEG polymers that are functionalized with either Lys or TG substrates to form synthetic hydrogels. Moreover, we have shown that the FXIIIa-catalyzed coupling scheme allows for the covalent incorporation of growth factors during the formation of these PEG hydrogels, without compromising the protein's bioactivity [41] [42] . Here, we aim to use this enzymatic reaction to site-specifically immobilize growth factors or other bioactive molecules on a surface.
Design of the surface modification scheme
To probe the specificity of the immobilization scheme we developed an approach that takes advantage of the above mentioned patterning technique; MAPL. In a first step, as depicted in 
Synthesis and characterization of PLL-g-PEG-TG
In order to position molecules on a surface, patterning strategies such as photolithographic, microfluidic, electrochemical techniques can be used. The PLL-g-PEG technology besides providing non-fouling properties to negative charged surfaces such as metals 29, 46, 48 , has been used together with MAPL to spatially arrange biologically active molecules like RGD on these surfaces and thus enable selective cell adhesion 27 .
To allow the enzyme FXIIIa to locally and specifically interact with the protein-resistant surface coating, we functionalized the PLL-g-PEG copolymer with a pending TG substrate sequence (PLL-g-PEG-TG). PLL-g-PEG-TG was synthesized and characterized by 1 Figures S1, S2, S3 ). 29, 48 . Based on the grafting ratio and the adsorbed polymer mass of our polymer, we calculated the surface density of the 11 immobilized TG-peptide moieties and the distance between them on a titanium-coated surface, and obtained 9.1 pmol/cm 2 and 4.6 nm respectively, similar to values of peptide moieties reported by other groups [27] [28] [29] .
H-NMR and OWLS (data included in Supporting information
Patterning of FITC-labelled Lys substrates
Since the coating of titanium-coated surfaces with PLL-g-PEG-TG proved to be resistant to protein adsorption (Supporting information Figure S2 ), we next created patterns of functionalized PLL-g-PEG-TG copolymers in a non-fouling PLL-g-PEG background by MAPL. We wanted to test whether the TG domains on the surface of PLL-g-PEG were accessible for tethering of biomolecules by FXIIIa. Therefore, we designed a short peptide sequence consisting on the TG-counter reactive substrate for FXIIIa followed by a short linker and fluorescein; Lys-FITC, which allowed us to directly follow the coupling reaction to the free pending TG peptide on the surface. After the reaction of Lys-FITC (50 μM) in presence of FXIIIa and calcium ions, the surfaces were washed thoroughly and analyzed by epifluorescence microscopy. In initial experiments the corresponding pattern of 60 x 60 µm green squares (false colored), separated by 100 µm, could be visualized at a wavelength of 470 nm on a dark background ( Figure 2a) . As negative control we performed a competitive assay using a large excess of soluble TG over bond TG substrates. The addition of TG-RGD (200 μM) in the Lys-FITC (50 μM) mixture resulted in a surface with an undetectable fluorescence pattern (Figure 2b ). These results imply that the TG domains on the surface were still functional and accessible for FXIIIa and that binding of the Lys-FITC molecules to the surface was indeed mediated by FXIIIa activity.
Enzymatic tethering of the integrin binding ligand RGD
Next, we wanted to test whether this modification scheme could be used to tether biologically relevant molecules. Previous findings indicated that functionalized PLL-g-PEG-RGD on metal implant surfaces sustained the adhesion of cells and could be used for tissue engineering applications such as the development of biomedical implants with improved healing and performance in vivo 13, 29 . To prove the specific coupling of Lys-RGD to PLL-g-PEG-TG coated surface via FXIIIa reaction, Nb 2 O 5 -coated surfaces were patterned with either PLL-g-PEG-TG or PLL-g-PEG-FITC on a cell-and protein-resistant background. After incubation with the Lys-RGD containing reaction mix, the non-bound ligands were carefully removed by rinsing. The presence and availability of the RGD peptide was assessed by allowing adhesion of MC3T3-E1 preosteoblastic cells for 4 hours under low serum (0.1%) cell culture conditions. As expected, cells exclusively attached to the areas were PLL-g-PEG-TG was immobilized (Figure 2c ) and neither to the immobilized PLL-g-PEG-FITC ( Figure   12 2d) nor to the PLL-g-PEG background, as shown by epifluorescence microscope imaging.
These results prove that the squares covered by PLL-g-PEG-TG translate into bio-adhesive patterns (RGD), and that the Lys-RGD ligands tethered to the surface are available to the cells. 
Theoretical RGD ligand density
In this study we did not evaluate the influence of the RGD ligand density on cell spreading or focal adhesion formation. However, we calculated the maximum theoretical Lys-RGD surface .
In situ surface modification by OWLS
Besides testing the specificity of FXIIIa surface modification by MAPL, we also wanted to determine the amount of ligands that can be coupled to our surfaces by FXIIIa enzymatic reaction. Thus, we monitored the adsorption of ligands on PLL-g-PEG-TG-coated waveguides (TiO 2 -coated) in situ by OWLS (Supporting information Figure S4 for a representative OWLS experiment; two immobilization steps). Prior to enzymatic modification of PLL-g-PEG-TG-coated surfaces, we tested the resistance of the coated-surfaces to BSA (3%) and to the effect of calcium ions (25mM) (data not shown). Experiments shown in Based on the polymer configuration and on previous work by other groups 27 , the probability that a fraction of TG ligands on the surface, is embedded within the dynamic PEG-brush during the 30 min incubation period is very low. The coupling efficiency of the enzyme based on previous work should be ca. 80-85% [41] [42] . This later reasoning is supported by the in situ increase in mass measured for Lys-FITC, a small molecule which diameter we assumed to be < 4.6 nm (theoretical distance between TG moieties ca. 4.6 nm). In the case of 8-arm Lys-PEG (ca. 20-30 nm in diameter), we believe that each molecule tethered to the surface blocks the access of ca. 10 TG moieties due to steric hindrance. Both this steric hindrance and the enzymatic efficiency, could explain the mass adsorption quantified by OWLS in the case of 8-arm Lys-PEG (Supporting information Figure S3 ).
Surface immobilization of vascular endothelial growth factor by MAPL and OWLS
Once we proved that the TG domains immobilized on the surface can be used for the site- (Supporting information Figure S3 ). As we have used excess of TG-VEGF 121 (5.4 µg) for the immobilization, we assume that the amount of immobilized growth factor cannot be further increased. When considering the diameter of TG-VEGF 121 (mol wt 32,000 g/mol), based on reported VEGF crystal structures [52] [53] , to be in the range of 5 nm the limited growth factor coupling is most likely not due to sterical hindrance. There is the possibility that one homodimeric TG-VEGF 121 molecule interacts with more than two Lys moieties belonging to either the same or to a different 8-arm Lys-PEG molecule. However, at this stage we cannot provide enough evidence to discuss further scenarios that could explain the observed immobilization ratio. 
Stepwise formation of surface immobilized hydrogel-like structures
Since free and functional substrate domains were observed after individual reaction steps, we followed the build-up of a "layer-by-layer" PEG-like hydrogel. Such a system could be used to form well-organized surface immobilized growth factor depots. The stepwise FXIIIacatalyzed immobilization of Lys-PEG (27.1 ± 3 ng/cm 2 ) followed by TG-PEG (24.2 ± 3.5 ng/cm 2 ) and subsequently by Lys-PEG (25.1 ± 3.3 ng/cm 2 ) was monitored by OWLS. We observed a constant increment of mass for all the steps (Figure 3d ). Also for this scenario, we believe to reach the maximum amount that can be immobilized. As previously discussed, after the first immobilization with Lys-PEG we consider our surface to be saturated with a monolayer of Lys-PEG molecules. For the two subsequent immobilization steps (TG-PEG and Lys-PEG) our calculations indicate an interaction ratio of 1 to 1, which suggests that a monolayer of PEG is being immobilized (Figure 4a ) with each step.
In Figure 4b we contemplate a possible scenario with multifunctional patterned 3D hydrogellike structures. We exemplify the immobilization of a first layer of Lys-PEG followed by a layer of TG-PEG and a third layer of Lys-PEG. The two first PEG molecules have been previously modified to contain one ligand (same or different) per molecule. The presented platform, as it is flexible in design, could include PEG molecules variable in number and size of arms. Furthermore, PEG molecules could be functionalized with ligands prior to or directly upon immobilization to the surface. In combination with other patterning techniques this layer-by-layer approach could even be used on hydrogel substrates. Together, we think that this stepwise build-up of hydrogel-like structures extends the possibilities of surface confined growth factor patterns to more complex 3D arrangement of biomimetic surface immobilized hydrogel-like substrates. 
Conclusions
We demonstrated an FXIIIa-catalyzed coupling scheme for site-specific tethering of ligands onto a surface that preserves the protein's bioactivity. Our surface modification method is based on the positioning of substrates for FXIIIa on a surface and their usage as initiator molecules for the further coupling of ligands. The ligands have been synthesized such that they comprised one of the counter reactive substrates for the enzyme. We showed that by using the previously described MAPL patterning technology, it is possible to have control over the spatial arrangement of the FXIIIa substrates on the surface. By applying a sitespecific FXIIIa-catalyzed enzymatic reaction it is also possible to translate this physical arrangement into a bioactive pattern, providing cells not only with adhesive-sites but also with morphogenes such as endothelial cell specific mitogen; TG-VEGF 121 . In addition, we provided evidence that this enzymatic approach allows a stepwise formation of more complex arrangements and even combinations of bioactive molecules. By recombinant protein expression and chemical synthesis a tool box with bioligands engineered to contain substrates for FXIIIa can be relatively easy established. These ligands when used together with our sitespecific surface immobilization technique will enable the formation of complex arrangements and combinations of bioactive molecules. We therefore believe that this is a versatile and powerful 2D platform to study cell-cell and cell-matrix interactions.
Supporting Information Available:
PDF file containing four Figures. 1 H-NMR analysis of the synthesized PLL-g-PEG-TG copolymer ( Figure S1 ). In situ OWLS adsorption of PLL-g-PEG-TG on a titanium-coated waveguide and protein resistance of the adsorbed polymer layer (0.3% BSA). The surface was also tested for incubation with calcium chloride (25mM) and its resistance to protein adsorption was again tested (3% BSA) ( Figure S2) . A summary of the PLL-g-PEG-TG characterization by 1 H-NMR and OWLS (molecular weight, grafting ratio, fraction of functionalized PEG, polymer adsorbed mass and its protein resistance); theoretical peptide densities based on experimental values (theoretical TG peptide surface densities, distance between the immobilized TG moieties, molecular weight of ligands used in the study and theoretical ligands surface densities) and theoretical immobilization rates on the surface ( Figure S3 ). A representative in situ OWLS immobilization graphic; 8-arm Lys-PEG followed by TG-VEGF 121 ( Figure S4 ). This material is available free of charge via the Internet at http://pubs.acs.org.
